Skill Guide

Drug discovery ML pipelines including virtual screening and ADMET prediction

The integrated use of machine learning models to automate and optimize the multi-stage process of identifying therapeutic compounds, from virtual screening of chemical libraries to the prediction of Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties.

This skill compresses the drug discovery timeline from years to months by prioritizing high-potential candidates in silico, drastically reducing expensive wet-lab failures. It directly impacts R&D ROI by increasing the probability of clinical success and enabling precision in compound optimization.

1 Careers

1 Categories

9.2 Avg Demand

15% Avg AI Risk

How to Learn Drug discovery ML pipelines including virtual screening and ADMET prediction

Focus on three pillars: 1) Cheminformatics fundamentals (SMILES, molecular descriptors, fingerprints like ECFP), 2) Core ML for graphs (GNNs, message-passing) and representations, 3) Standard data sources (ChEMBL, PubChem, ZINC).

Transition from theory to pipeline construction: Practice building end-to-end pipelines using tools like DeepChem and RDKit. Common pitfalls include data leakage in scaffold splitting and over-reliance on simplistic ADMET models without domain-specific feature engineering.

Mastery involves architecting federated learning pipelines for proprietary data, designing multi-objective optimization loops for lead optimization, and strategically aligning computational outputs with medicinal chemistry SARs to guide IP strategy.

Practice Projects

Beginner

Project

Build a Binary Activity Classifier

Scenario

Predict whether a compound is active or inactive against a specific kinase target (e.g., EGFR) using a public dataset like ChEMBL.

How to Execute

1) Extract and clean data from ChEMBL for a single target. 2) Use RDKit to generate Morgan fingerprints. 3) Train a Random Forest or XGBoost model using scaffold splitting. 4) Evaluate using AUC-ROC and perform a basic feature importance analysis.

Intermediate

Project

Virtual Screening Campaign

Scenario

You have a novel target with a known active compound. Screen a diverse library (like ZINC) to find new scaffolds.

How to Execute

1) Build a 3D shape-based or pharmacophore model from the known active. 2) Screen a subset of ZINC using ROCS or a deep learning virtual screener. 3) Re-rank hits using a docking program (AutoDock Vina). 4) Validate top hits with a simple ADMET prediction (Lipinski's Rule of 5, solubility).

Advanced

Project

End-to-End Lead Optimization Pipeline

Scenario

Design a system that takes an initial hit compound and generates optimized analogs with improved potency, selectivity, and ADMET profiles.

How to Execute

1) Implement a generative model (e.g., a VAE or RNN) conditioned on desired properties. 2) Integrate multi-task ADMET predictors (solubility, clearance, hERG). 3) Build an active learning loop where synthetic feasibility scores and docking energies guide the generation. 4) Output a ranked list of molecules with predicted properties and synthetic routes (using a retrosynthesis tool).

Tools & Frameworks

Core Cheminformatics & ML Libraries

RDKitDeepChemPyTorch Geometric

RDKit is the industry standard for molecular processing. DeepChem provides accessible APIs for building graph neural networks on chemical data. PyG is used for implementing custom graph neural network architectures.

Virtual Screening & Docking Software

AutoDock VinaOpen BabelGROMACS

AutoDock Vina is used for molecular docking. Open Babel handles file format conversion and basic manipulations. GROMACS is for molecular dynamics simulations to assess binding stability.

Data Platforms & Databases

ChEMBLPubChemZINC

ChEMBL provides curated bioactivity data. PubChem is a vast chemical repository. ZINC is a database of commercially available compounds for virtual screening.

Interview Questions

Answer Strategy

The interviewer is testing for practical model debugging beyond metrics. The answer must address data leakage, assay translation issues, and domain applicability. A strong response would outline steps: 1) Check for data leakage (e.g., shared scaffolds between train/test), 2) Analyze the chemical space of the test set vs. the virtual library, 3) Examine the activity cliff problem (small structural changes causing large activity differences), 4) Suggest an enrichment analysis and consider using a docking consensus or ADMET filters to refine the hit list.

Answer Strategy

This tests strategic decision-making in drug discovery. The answer should reference the multi-parameter optimization (MPO) framework. A professional response: 'I would use a weighted MPO score incorporating both target engagement (potency, selectivity) and developability (ADMET) parameters, aligned with the project's therapeutic area (e.g., CNS requires high metabolic stability). I would also model the structure-property relationships to see if the potent compound's liabilities are addressable via medicinal chemistry without sacrificing key activity.'